共 59 条
- [1] Dandana A(2016)Gaucher disease: clinical, biological and therapeutic aspects Pathobiology 83 13-23
- [2] Ben Khelifa S(2003)Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3 Neurobiology of Disease 14 595-601
- [3] Chahed H(2013)Proton MR spectroscopy of the brain in children with neuronopathic Gaucher’s disease Eur Radiol 23 3005-3011
- [4] Miled A(2007)Neurological and brain MRS findings in patients with Gaucher disease type 1 Mol Genet Metab 91 390-395
- [5] Ferchichi S(2006)Persistent diffusion abnormalities in the brain stem of three children with mitochondrial diseases AJNR Am J Neuroradiol 27 1924-1926
- [6] Schueler U.H(2005)Diffusion-weighted imaging of acute excitotoxic brain injury AJNR Am J Neuroradiol 26 216-228
- [7] Kolter T(2011)Brain white matter abnormalities in paediatric Gaucher type I and type III using diffusion tensor imaging J Inherit Metab Dis 34 549-553
- [8] Kaneski C.R(2010)Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits Hum Mol Genet 19 1088-1097
- [9] Blusztajn J.K(2006)Brain development in infantile-onset Pompe disease treated by enzyme replacement therapy Pediatr Res 60 349-352
- [10] Herkenham M(undefined)undefined undefined undefined undefined-undefined